Catherine O. Falade

Polymorphisms in Plasmodium falciparum Chloroquine Resistance Transporter and Multidrug Resistance 1 Genes: Parasite Risk Factors That Affect Treatment Outcomes for P. falciparum Malaria After Artemether-Lumefantrine and Artesunate-Amodiaquine

Meera Venkatesan, Nahla B. Gadalla, Kasia Stepniewska et al. · American Journal of Tropical Medicine and Hygiene · 2014 · 292 citations · Full text

Antiparasitic Agent, Malaria, Genetic Epidemiology +18

Moral Standards for Research in Developing Countries from "Reasonable Availability" to "Fair Benefits"

M. El Setouhy, Tsiri Agbenyega, Francis Anto et al. · The Hastings Center Report · 2004 · 220 citations

Efficacy and safety of artemether–lumefantrine (Coartem®) tablets (six-dose regimen) in African infants and children with acute, uncomplicated falciparum malaria

Catherine O. Falade, Michael Makanga, Zul Premji et al. · Transactions of the Royal Society of Tropical Medicine and Hygiene · 2005 · 160 citations

African Infants, Translational Medicine, Uncomplicated Falciparum Malaria +11

Epidemiology of congenital malaria in Nigeria: a multi‐centre study

Catherine O. Falade, Olugbenga Ayodeji Mokuolu, Henrietta U. Okafor et al. · Tropical Medicine & International Health · 2007 · 134 citations

Knowledge and utilization of intermittent preventive treatment for malaria among pregnant women attending antenatal clinics in primary health care centers in rural southwest, Nigeria: a cross-sectional study

Stella Akinleye, Catherine O. Falade, IkeOluwapo O. Ajayi · BMC Pregnancy and Childbirth · 2009 · 108 citations · Full text